Close

Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock Jun 30, 2023 04:02PM
Axsome Therapeutics (AXSM) Prices 3M Share Offering at $75/sh Jun 28, 2023 09:29AM
Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock Jun 28, 2023 09:28AM
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update May 10, 2021 07:00AM
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update May 10, 2021 07:00AM


Jun 4, 2020 07:00AM Axsome Therapeutics to Present at Upcoming Investor Conferences
Jun 4, 2020 07:00AM Axsome Therapeutics to Present at Upcoming Investor Conferences
Mar 12, 2020 07:00AM Axsome Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Mar 12, 2020 07:00AM Axsome Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Jan 13, 2020 11:01AM Axsome Therapeutics (AXSM) Highlighted as Takeover Target by Analyst
Dec 30, 2019 10:54AM William Blair Reiterates Outperform Rating on Axsome Therapeutics (AXSM); Top Pick and on Take-Out Watch List
Dec 23, 2019 04:19PM Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dec 23, 2019 04:19PM Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dec 19, 2019 07:06AM Axsome Therapeutics (AXSM) Prices 2M Share Offering at $87
Dec 19, 2019 07:05AM Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock
Dec 19, 2019 07:05AM Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock
Sep 18, 2019 04:00AM William Blair Starts Axsome Therapeutics (AXSM) at Outperform